Reaction Details |
| Report a problem with these data |
Target | Neuropeptide Y receptor type 5 |
---|
Ligand | BDBM50265338 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_496407 (CHEMBL1001157) |
---|
IC50 | >1000±n/a nM |
---|
Citation | Ogino, Y; Ohtake, N; Nagae, Y; Matsuda, K; Moriya, M; Suga, T; Ishikawa, M; Kanesaka, M; Mitobe, Y; Ito, J; Kanno, T; Ishihara, A; Iwaasa, H; Ohe, T; Kanatani, A; Fukami, T Design, syntheses, and structure-activity relationships of novel NPY Y5 receptor antagonists: 2-{3-Oxospiro[isobenzofuran-1(3H),4'-piperidin]-1'-yl}benzimidazole derivatives. Bioorg Med Chem Lett18:5010-4 (2008) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Neuropeptide Y receptor type 5 |
---|
Name: | Neuropeptide Y receptor type 5 |
Synonyms: | NPY-Y5 | NPY-Y5 receptor | NPY5-R | NPY5R | NPY5R_HUMAN | NPYR5 | NPYY5 | Neuropeptide Y receptor type 5 | Neuropeptide Y receptor type 5 ( NPY Y5) | Y5 receptor |
Type: | Enzyme |
Mol. Mass.: | 50746.64 |
Organism: | Homo sapiens (Human) |
Description: | Q15761 |
Residue: | 445 |
Sequence: | MDLELDEYYNKTLATENNTAATRNSDFPVWDDYKSSVDDLQYFLIGLYTFVSLLGFMGNL
LILMALMKKRNQKTTVNFLIGNLAFSDILVVLFCSPFTLTSVLLDQWMFGKVMCHIMPFL
QCVSVLVSTLILISIAIVRYHMIKHPISNNLTANHGYFLIATVWTLGFAICSPLPVFHSL
VELQETFGSALLSSRYLCVESWPSDSYRIAFTISLLLVQYILPLVCLTVSHTSVCRSISC
GLSNKENRLEENEMINLTLHPSKKSGPQVKLSGSHKWSYSFIKKHRRRYSKKTACVLPAP
ERPSQENHSRILPENFGSVRSQLSSSSKFIPGVPTCFEIKPEENSDVHELRVKRSVTRIK
KRSRSVFYRLTILILVFAVSWMPLHLFHVVTDFNDNLISNRHFKLVYCICHLLGMMSCCL
NPILYGFLNNGIKADLVSLIHCLHM
|
|
|
BDBM50265338 |
---|
n/a |
---|
Name | BDBM50265338 |
Synonyms: | 2-(3-oxo-3H-spiro[isobenzofuran-1,4'-piperidine]-1'-yl)-1H-benzo[d]imidazole-5-carboxylic acid | CHEMBL527016 |
Type | Small organic molecule |
Emp. Form. | C20H17N3O4 |
Mol. Mass. | 363.3667 |
SMILES | OC(=O)c1ccc2nc([nH]c2c1)N1CCC2(CC1)OC(=O)c1ccccc21 |
Structure |
|